期刊文献+

帕金森病患者中miR-146a表达意义及与炎症因子的相关性分析 被引量:1

Significance of miR-146a expression in Parkinson's patients and analysis of its correlation with inflammatory factors
原文传递
导出
摘要 目的 探讨帕金森病(PD)患者血清miR-146a表达水平的变化,分析其与炎症因子的相关性。方法 选取我院2017年8月~2021年3月收治的PD患者108例作为PD组,同时纳入同期体检的健康志愿者87例作为对照组。比较两组血清miR-146a表达量及白介素-1β(IL-1β)、IL-2、IL-6、超敏C反应蛋白(hs-CRP)、肿瘤坏死因子-α(TNF-α)水平。根据患者miR-146a表达量分成高表达组、低表达组,分析其表达与PD临床特征的关系。绘制受试者工作特征曲线(ROC)分析血清miR-146a评估PD的曲线下面积(AUC)。经Pearson线性相关分析血清miR-146a表达水平与炎症因子的相关性。结果 PD组血清miR-146a表达低于对照组,血清IL-1β、IL-2、IL-6、TNF-α、hs-CRP水平高于对照组(P<0.05)。miR-146a低表达组UPDRS评分≥50分、H-Y 3~5级、认知障碍占比高于高表达组(P<0.05)。血清miR-146a表达评估PD的AUC为0.795。Pearson线性相关分析提示血清miR-146a表达与IL-1β、IL-2、IL-6、TNF-α、hs-CRP水平呈负相关(P<0.05)。结论 PD患者血清miR-146a表达水平下调,且与炎症因子密切相关,其对PD诊断有一定价值。 Objective To explore the changes of serum miR-146a expression level in patients with Parkinson's disease(PD),and analyze its correlation with inflammatory factors.Methods A total of 108 PD patients admitted to our hospital from August 2017 to March 2021 were selected as the PD group,and 87 healthy volunteers were included as the control group.The serum miR-146a expression and the levels of interleukin-1β(IL-1β),IL-2,IL-6,high-sensitivity C-reactive protein(hs-CRP) and tumor necrosis factor-α(TNF-α) were compared between the two groups.According to the expression of miR-146a,the patients were divided into high expression group and low expression group,and the relationship between its expression and the clinical characteristics of PD was analyzed.ROC was drawn to analyze the AUC of serum miR-146a to assess PD.The correlation between serum miR-146a expression level and inflammatory factors was analyzed by Pearson linear correlation.Results The expression of serum miR-146a in the PD group was lower than control group,and the levels of serum IL-1β,IL-2,IL-6,TNF-α,and hs-CRP were higher than those in the control group(P<0.05).The UPDRS score of the miR-146a low expression group was ≥50 points,H-Y grade 3 to 5,and the proportion of cognitive impairment was higher than the high expression group(P<0.05).Serum miR-146a expression assessed PD AUC of 0.795.Pearson linear correlation analysis showed that serum miR-146a expression was negatively correlated with IL-1β,IL-2,IL-6,TNF-α,and hs-CRP levels(P<0.05).Conclusion The expression level of serum miR-146a in PD patients is down-regulated and is closely related to inflammatory factors,which has a certain value in the diagnosis of PD.
作者 秦和平 蔡来新 王秋女 Qin Heping;Cai Laixin;Wang qiunv(Neurology,Hainan Second People's Hospital,Hainan Wuzhishan,572299,China)
出处 《立体定向和功能性神经外科杂志》 2023年第2期65-70,共6页 Chinese Journal of Stereotactic and Functional Neurosurgery
关键词 帕金森病 微小核糖核酸-146a 炎症因子 相关性 认知障碍 Parkinson's disease MicroRNA-146a Inflammatory factors Correlation Cognitive impairment
  • 相关文献

参考文献14

二级参考文献87

  • 1胡秋侠,李博,佘若男,吴系美,谭锦辉,胡建云,唐群芳.miR-146a rs2910164位点多态性与类风湿关节炎病情活动的相关性[J].中华医学遗传学杂志,2019,36(5):505-507. 被引量:9
  • 2张振馨.帕金森病的诊断[J].中华神经科杂志,2006,39(6):408-409. 被引量:614
  • 3Zhang ZX, Roman GC, Hong Z,et al. Parkinson's disease inChina: prevalence in Beijing, Xian, and Shanghai[ J]. Lancet,2005,365(9459): 595-597.
  • 4Postuma RB, Berg D, Stem M, et al. MDS clinical diagnosticcriteria for Parkinson、disease[ J]. Mov Disord, 2015,30( 12):1591-1601. DOI: 10.1002/mds.26424.
  • 5Chaudhuri KR, Healy DG, Schapira AH, et al. Non-motorsymptoms of Parkinson's disease : diagnosis and management[ J ].Lancet Neurol, 2006,5(3): 235-245.
  • 6Goetz CG,Tilley BC, Shaftman SR,et al. Movement DisorderSociety-sponsored revision of the Unified Parkinson; s DiseaseRating Scale ( MDS-UPDRS) . scale presentation and clinimetrictesting results [ J ]. Mov Disord, 2008 , 23 ( 15): 2129-2170.DOI: 10.1002/mds. 22340.
  • 7Shah M, Muhammed N, Findley LJ, et al. Olfactory tests in thediagnosis of essential tremor [ J ]. Parkinsonism Relat Disord,2008,14(7) : 563-568. DOI: 10. 1016/j. parkreldis. 2007. 12.006.
  • 8Wenning GK, Shephard B, Hawkes C, et al. Olfactory functionin atypical parkinsonian syndromes [ J ]. Acta NeurologicaScandinavica, 1995,91(4): 247-250.
  • 9Muller A, Mtingersdorf M, Reichmann H, et al. Olfactoryfunction in Parkinsonian syndromes[ J]. J Clin Neurosci, 2002 , 9(5): 521-524.
  • 10Goldstein DS,Holmes C,Bentho O,et al. Biomarkers to detectcentral dopamine deficiency and distinguish Parkinson diseasefrom multiple system atrophy [ J ]. Parkinsonism Relat Disord,2008,14(8): 600-607. DOI: 10. 1016/j. parkreldis. 2008. 01.010.

共引文献1163

同被引文献12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部